Nathaniel Chin, MD, discusses new therapies, early detection and screening for Alzheimer’s disease in a two-part video series produced by The New England Journal of Medicine.
When researchers test motor skills, hearing, vision and smell in people in their midlife, they are better able to identify those who may develop cognitive decline or impairment 10 years later, according to a new study by researchers at the University of Wisconsin School of Medicine and Public Health.
Nathaniel Chin, MD, penned a guest essay recently featured in Newsday explaining how emerging Alzheimer’s treatments raise the stakes for understanding the distinction between Alzheimer’s disease and dementia.
Researchers from the Wisconsin Alzheimer’s Disease Research Center ranked highly in the Blue Ridge Institute for Medical Research’s rankings for funding from the National Institutes on Health.
Dr. Nathaniel Chin participated in POLITICO’s ‘How Fast Can We Solve Alzheimer’s’ event with advocates and legislators to discuss the path forward for better collaboration among health systems and industry.
The news report interviews a participant enrolled in the African Americans Fighting Alzheimer’s in Midlife (AA-FAIM) study and describes the health disparities in Alzheimer’s disease.
A new study by researchers at the University of Wisconsin School of Medicine and Public Health suggests a link between gut inflammation and changes in the brain and declines in memory, further supporting a connection between the gut and brain in Alzheimer’s disease.
On the show, host Rob Ferrett asked Drs. Nathaniel Chin and Kimberly Mueller questions regarding the connections between hearing loss and a person’s risk for dementia.
The annual award was created by former Madison Mayor Dave Cieslewicz and the Common Council to honor Madison residents who exemplify Jeff Erlanger’s model of fairness, openness and civility in public discourse.